Market Place
Sourcing Support
AUM doses first patient in trial of MSS CRC therapy
31 May 2023 //
CLINICAL TRIALS ARENA
AUM Biosciences to Participate in Inaugural EF Hutton Global Conference
26 Apr 2023 //
GLOBENEWSWIRE
AUM Biosciences Receives U.S. FDA Rare Pediatric Disease Designation for AUM302
05 Jan 2023 //
GLOBENEWSWIRE
AUM Biosciences Receives FDA Orphan Drug Designation for AUM302
30 Nov 2022 //
GLOBENEWSWIRE
AUM Receives HREC Approval to Commence PII Trial of AUM001
15 Nov 2022 //
GLOBENEWSWIRE
AUM Biosciences to Participate in BioCentury-BayHelix East-West BioPharma Summit
04 Nov 2022 //
GLOBENEWSWIRE
Cancer-focused Aum is latest biotech to pursue SPAC route
21 Oct 2022 //
FIERCEBIOTECH
AUM Bio & Asymchem Complete PhII API Production Campaign of Novel TRK Inhibitor
20 Oct 2022 //
PRNEWSWIRE
AUM Biosciences merges with Nasdaq listed Mountain Crest
20 Oct 2022 //
ECONOMIC TIMES
AUM Announces Plans to Become a Public Company via Merger
19 Oct 2022 //
GLOBENEWSWIRE
AUM Biosciences Receives FDA Orphan Drug Designation for AUM601
18 Aug 2022 //
GLOBENEWSWIRE
AUM Biosciences Announces FDA IND Authorization for Global PII Trial of AUM001
07 Jun 2022 //
GLOBENEWSWIRE
AUM Biosciences Appoints Scott Jordan as Head of Corporate Development
17 May 2022 //
GLOBENEWSWIRE
Singapore-based AUM Biosciences partners with Roche for cancer drug trial
11 May 2022 //
BIOSPECTRUMASIA
AUM Bio Enters into Collaboration with Roche for Clinical Development of AUM001
10 May 2022 //
GLOBENEWSWIRE
AUM Biosciences inks trial collaboration with Merck for colorectal cancer
06 May 2022 //
BIOSPECTRUMASIA
AUM Bio Announces Trial Collaboration and Supply Agreement with MSD for AUM001
05 May 2022 //
GLOBENEWSWIRE
AUM Biosciences and HANDOK Presented Phase 1 Data for AUM-601 at ESMO
19 Apr 2022 //
GLOBENEWSWIRE
AUM Bio Identifies Asymchem as CDMO Partner of Choice for Novel TRK inhibitor
11 Jan 2022 //
PRNEWSWIRE
Singapore`s AUM Biosciences Earns $27M in Series A Round
14 Oct 2021 //
BIOSPACE
AUM Biosciences announces closing of $27 million in a “Series A” round
13 Oct 2021 //
EXPRESS PHARMA
AUM Biosciences completes $27 mn series A funding
13 Oct 2021 //
PHARMABIZ
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.